ArticleTaiwan journal of ophthalmology
Intraocular pressure changes after posterior sub-Tenon injection of triamcinolone acetonide in a sample of Iraqi patients with noninfectious uveitis.
Article in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeGiven the wide variation in intraocular pressure (IOP) response after posterior sub-Tenon triamcinolone acetonide (STTA) injection among different ethnicities, this study was conducted to evaluate the incidence of raised IOP following injection with posterior STTA in a sample of Iraqi patients with noninfectious uveitis and evaluate the main predictors of increased IOP. MATERIALS AND
methodsThis was a prospective clinical study conducted at the Ibn Al-Haitham Eye Teaching Hospital Uveitis Clinic between October 2, 2022, and April 1, 2024. The study included patients with noninfectious uveitis requiring treatment with posterior STTA injection. The included patients had a baseline IOP measurement before receiving 40 mg of triamcinolone acetonide. IOP measurements were then taken at 1 week and 1 month after the injection using a Keeler applanation tonometer. All measurements were performed by the same experienced ophthalmologist using the same device.
resultsA total of 60 patients with noninfectious uveitis who received posterior STTA injections were included in the study, consisting of 29 females and 31 males. The mean age in this study was 30.52, with a standard deviation (STD) 17.19. Thirty-one patients (51.7%) had significant IOP elevation over 1 month (more than 21 mmHg). Younger age was found to be significantly related to higher elevation in IOP over time (
conclusionThere was a significant increase in IOP over the period from 1 week to 1 month. The change in IOP during this time was significantly related to age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.